Illumina Inc ILMN

Technology Scientific & Technical Instruments

Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

NDAQ:ILMN - Post by User

Illumina Inc

<< Previous

Bullboard Posts

Next >>

Post by R_J_on Dec 03, 2020 1:33am

243 Views

Post# 32024224

End of Month - November 2020

End of the Month Report for November 2020 for Illumina Inc.
-
ILMN closed on 11/30/2020 at US$ 322.09
ILMN closed on 10/30/2020 at US$ 292.70
-
This is a   10.0% gain, a US$ 29.39 gain, for November
-
S&P 500 Index, @ 3621.63 gained 10.8% in November. [14.9% above its MA(200) @ 3152.9]
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's MA(200) ended November at US$323.99
ILMN is now 0.6% below its MA(200).
-
News Release on the ILMN Website in November
-
Nov 18, 2020
Illumina to Webcast Upcoming Investor Conference Presentation
-
Nov 12, 2020
Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit
-
Who is in charge?
Francis A. DeSouza, CEO
-
RJ

<< Previous

Bullboard Posts

Next >>

Canada’s federal budget: What investors need to know